image
Healthcare - Medical - Devices - NASDAQ - IL
$ 5.24
-4.55 %
$ 334 M
Market Cap
-5.76
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 22, 2025.

The intrinsic value of one NNOX stock under the worst case scenario is HIDDEN Compared to the current market price of 5.24 USD, Nano-X Imaging Ltd. is HIDDEN

This DCF valuation model was last updated on May, 22, 2025.

The intrinsic value of one NNOX stock under the base case scenario is HIDDEN Compared to the current market price of 5.24 USD, Nano-X Imaging Ltd. is HIDDEN

This DCF valuation model was last updated on May, 22, 2025.

The intrinsic value of one NNOX stock under the best case scenario is HIDDEN Compared to the current market price of 5.24 USD, Nano-X Imaging Ltd. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart NNOX

image
$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.0$6.0$6.0$5.0$5.0$4.0$4.0Dec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 May
FINANCIALS
11.3 M REVENUE
13.91%
-56.7 M OPERATING INCOME
9.34%
-53.5 M NET INCOME
11.95%
-36.6 M OPERATING CASH FLOW
18.27%
-20.1 M INVESTING CASH FLOW
-56.59%
39.5 M FINANCING CASH FLOW
44.96%
3 M REVENUE
-1.02%
-15 M OPERATING INCOME
-5.91%
-14.1 M NET INCOME
-3.09%
-10.5 M OPERATING CASH FLOW
-29.58%
-26.2 M INVESTING CASH FLOW
-457.50%
37.8 M FINANCING CASH FLOW
2234.24%
Balance Sheet Nano-X Imaging Ltd.
image
Current Assets 78.7 M
Cash & Short-Term Investments 73.2 M
Receivables 1.8 M
Other Current Assets 3.67 M
Non-Current Assets 131 M
Long-Term Investments 0
PP&E 49.2 M
Other Non-Current Assets 82.1 M
34.86 %23.43 %39.11 %Total Assets$210.0m
Current Liabilities 14 M
Accounts Payable 2.21 M
Short-Term Debt 3.81 M
Other Current Liabilities 7.96 M
Non-Current Liabilities 6.91 M
Long-Term Debt 3.64 M
Other Non-Current Liabilities 3.27 M
10.58 %18.23 %38.10 %17.43 %15.66 %Total Liabilities$20.9m
EFFICIENCY
Earnings Waterfall Nano-X Imaging Ltd.
image
Revenue 11.3 M
Cost Of Revenue 21.9 M
Gross Profit -10.6 M
Operating Expenses 46.1 M
Operating Income -56.7 M
Other Expenses -3.23 M
Net Income -53.5 M
20m20m10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)11m(22m)(11m)(46m)(57m)3m(54m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
-94.03% GROSS MARGIN
-94.03%
-502.93% OPERATING MARGIN
-502.93%
-474.31% NET MARGIN
-474.31%
-28.30% ROE
-28.30%
-25.48% ROA
-25.48%
-28.21% ROIC
-28.21%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Nano-X Imaging Ltd.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)20192019202020202021202120222022202320232024202420252025
Net Income -53.5 M
Depreciation & Amortization 11.7 M
Capital Expenditures -2.77 M
Stock-Based Compensation 7.26 M
Change in Working Capital -1.13 M
Others 215 K
Free Cash Flow -39.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Nano-X Imaging Ltd.
image
NNOX has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 13
6. Ownership
Insider Ownership Nano-X Imaging Ltd.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Nano-X Imaging Ltd. (NNOX) Q1 2025 Earnings Call Transcript Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q1 2025 Earnings Conference Call May 22, 2025 8:30 PM ET Company Participants Mike Cavanaugh - Investor Relations Erez Meltzer - Chief Executive Officer and Acting Chairman Ran Daniel - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Ross Osborn - Cantor Fitzgerald Scott Henry - Alliance Global Partners Operator Good day, and thank you for standing by. seekingalpha.com - 1 week ago
Nanox to Report First Quarter 2025 Financial Results on May 22, 2025 PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2025, before market open on Thursday, May 22, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. globenewswire.com - 3 weeks ago
Why Nano-X Imaging Stock Soared Today Nano-X Imaging (NNOX 15.78%), the Israeli X-ray imaging company that hopes to disrupt the medical devices market with a business model charging per X-ray delivered rather than simply selling X-ray machines, jumped in Thursday trading, rising 14.2% through 12:30 p.m. ET. fool.com - 1 month ago
Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X PETACH TIKVA, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Nanox.ARC X, its new multi-source digital tomosynthesis system. The FDA 510(k) clearance was received in less than 30 days from the date of submission and covers the production of tomographic images for general use, including the human musculoskeletal system and pulmonary, intra-abdominal and paranasal sinus indications, adjunctive to conventional radiography on adult patients. globenewswire.com - 1 month ago
Why Nanox Stock Slumped Today On Monday, many investors drew an X next to the name of Nano-X Imaging (NNOX -4.59%), also known as Nanox. The next-generation medical imaging specialist experienced a sell-off following its latest earnings release that morning, and by the end of the day, its price had fallen by almost 5%. fool.com - 2 months ago
Nano-X Imaging Ltd. (NNOX) Q4 2024 Earnings Call Transcript Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q4 2024 Earnings Conference Call March 31, 2025 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Erez Meltzer - Chief Executive Officer and Acting Chairman Ran Daniel - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Ross Osborn - Cantor Fitzgerald Scott Henry - Alliance Global Partners Jason Colbert - DeBoro Capital Operator Good day and thank you for standing by. seekingalpha.com - 2 months ago
Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe ADOPT Study Findings Highlight Nanox.AI's Role in Enhancing Fracture Detection and Healthcare Cost Savings globenewswire.com - 2 months ago
Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025 PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. globenewswire.com - 2 months ago
Is Nvidia's Favorite Autonomous Vehicle Stock a Buy? Nvidia (NASDAQ:NVDA) shocked the market last month by disclosing it had dumped all of its shares in artificial intelligence voice recognition expert SoundHound AI ( NASDAQ:SOUN ), Serve Robotics (NASDAQ:SERV), and Nano X Imaging (NASDAQ:NNOX). 247wallst.com - 2 months ago
Nanox to Present New Clinical Data on Nanox.ARC Advanced 3D Digital Tomosynthesis Imaging System at ECR 2025 PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will present data supporting the Nanox.ARC performance at the 2025 European Congress of Radiology (ECR), taking place February 26 – March 2 in Vienna, Austria. globenewswire.com - 3 months ago
Why SoundHound AI, Serve Robotics, and Nano-X Imaging Are Getting Crushed Today (Hint: It Has to Do With Nvidia) Shares of several artificial intelligence (AI) stocks in various sectors are getting crushed this morning after the AI chip king Nvidia revealed in documents filed with the Securities and Exchange Commission (SEC) that it exited its position in these companies. fool.com - 3 months ago
Nano-X Imaging: When Will The Hockey Stick Growth Happen? Nano-X Imaging is my speculative play for disruptive innovation in the biotech sector. With the S&P 500 at historical highs, lagging sectors like healthcare seem relatively attractive. The biotech sector's large market size and potential make it an intriguing investment opportunity. The AI push in health sector is a long-term tailwind. NNOX is positioned well in offering real value from the AI system. seekingalpha.com - 3 months ago
8. Profile Summary

Nano-X Imaging Ltd. NNOX

image
COUNTRY IL
INDUSTRY Medical - Devices
MARKET CAP $ 334 M
Dividend Yield 0.00%
Description Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
Contact Communications Center, Neve Ilan, 9085000 https://www.nanox.vision
IPO Date Aug. 21, 2020
Employees 165
Officers Ms. Tamar Aharon Cohen Executive Vice President, Chief Marketing Officer and Head of the Sales & Marketing Mr. James M. Dara GM of Source & Services Division and Head of Nanox USA Ms. Gali Yahav Attias Chief of Corporate Resources Sharon Saban SVice President of AI & Data Platforms Mr. Ofir Koren General Manager of Nanox.ARC Division Mr. Erez I. Meltzer Chief Executive Officer & Acting Chairman of the Board Ms. Marina Gofman Feler Chief Legal Officer Dr. Michael Yuz M.D., MBA President & CMO, USARAD Holdings Inc. Dr. Orit Wimpfheimer M.D. Chief Medical Officer & Vice President of Product Nanox AI Mr. Ran Daniel Chief Financial Officer